G
Geoffrey F. Joyce
Researcher at University of Southern California
Publications - 120
Citations - 6535
Geoffrey F. Joyce is an academic researcher from University of Southern California. The author has contributed to research in topics: Health care & Medicare Part D. The author has an hindex of 34, co-authored 113 publications receiving 5957 citations. Previous affiliations of Geoffrey F. Joyce include VA Palo Alto Healthcare System & Children's National Medical Center.
Papers
More filters
Journal ArticleDOI
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
TL;DR: Pharmacy benefit design represents an important public health tool for improving patient treatment and adherence and increased cost sharing is highly correlated with reductions in pharmacy use, but the long-term consequences of benefit changes on health are still uncertain.
Journal ArticleDOI
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Dana P. Goldman,Geoffrey F. Joyce,José J. Escarce,Jennifer E. Pace,Matthew D. Solomon,Marianne Laouri,Pamela B. Landsman,Steven M. Teutsch +7 more
TL;DR: The use of medications such as antihistamines and NSAIDs, which are taken intermittently to treat symptoms, was sensitive to co-payment changes, and other medications--antihypertensive, antiasthmatic, antidepressant, antihyperlipidemic, antiulcerant, and antidiabetic agents--also demonstrated significant price responsiveness.
Journal ArticleDOI
Male Urethral Stricture Disease
TL;DR: The impact of urethral stricture disease is estimated by determining its prevalence, costs and other measures of burden, including side effects and the need for surgical intervention, by analyzing public and private data sets.
Journal ArticleDOI
Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?
Christopher S. Saigal,Geoffrey F. Joyce,Geoffrey F. Joyce,Anga R. Timilsina,Anga R. Timilsina +4 more
TL;DR: The direct and indirect costs of nephrolithiaisis are substantial among working-age adults and interventions that prevent recurrence among known stone formers may be a cost-effective component of disease management programs.
Journal ArticleDOI
Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy
Samuel A. Bozzette,Samuel A. Bozzette,Samuel A. Bozzette,Geoffrey F. Joyce,Daniel F. McCaffrey,Arleen Leibowitz,Arleen Leibowitz,Sally C. Morton,Sandra H. Berry,Afshin Rastegar,David S. Timberlake,David S. Timberlake,Martin F. Shapiro,Martin F. Shapiro,Dana P. Goldman +14 more
TL;DR: The total cost of care for adults with HIV infection has declined since the introduction of highly active antiretroviral therapy, and there are large variations in expenditures across subgroups of patients.